ABVC BioPharma, Inc. (ABVC) vs MDxHealth S.A. (MDXH)

A side-by-side comparison of ABVC BioPharma, Inc. and MDxHealth S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ABVC

ABVC BioPharma, Inc.

$25M

$0.94HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT

MDXH

MDxHealth S.A.

$31M

$0.60HealthcareDelayed quote: Oct 6, 2026, 10:51 AM EDT

Total return — ABVC vs MDXH

growth of $100 · dividends reinvested · last 5y

ABVC -96.1% (-47.8%/yr)MDXH -95.0% (-45.1%/yr)MDXH compounded faster over this window

ABVC MDXH

ABVC vs MDXH: by the numbers

•MDXH is the larger company ($31M vs $25M market cap).
•Both run net losses; ABVC's is the smaller (0.00% vs -31.07% net margin).

Metrics side by side

Valuation

Metric	ABVC	MDXH
P/B ratio	2.39	N/A

Profitability

Metric	ABVC	MDXH
Gross margin	0.00%	59.74%
Operating margin	0.00%	-14.28%
Net margin	0.00%	-31.07%
ROE	-76.82%	N/A
ROIC	-53.34%	-15.35%

Growth (annualized)

Metric	ABVC	MDXH
Revenue CAGR (5Y)	N/A	42.35%
Total return CAGR (5Y)	-46.33%	N/A

Go deeper

Full ABVC analysis Full MDXH analysis Interactive comparison tool

Dig into the metrics

ABVC BioPharma ROE MDxHealth ROE ABVC BioPharma operating margin MDxHealth operating margin ABVC BioPharma revenue growth MDxHealth revenue growth ABVC BioPharma free cash flow MDxHealth free cash flow

ABVC BioPharma & MDxHealth appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.